# Exploring Immune Responses to SARS-CoV-2: Insights from Sinopharm (BBIBP-CorV)-Vaccinated Individuals in a Group of Venezuelan Admixed Volunteers

**Authors:** Alexis Hipólito García, Soriuska José Mayora, Christian Medina, Inírida Amada Belisario, Wendy Yaqueline Martínez, Francis Isamarg Crespo, Juan Bautista De Sanctis

PMC · DOI: 10.3390/biomedicines13071550 · 2025-06-25

## TL;DR

This study examines immune responses in Venezuelan volunteers vaccinated with Sinopharm BBIBP-CorV, finding a mild but significant long-term memory against SARS-CoV-2.

## Contribution

The study provides insights into immune memory in Sinopharm-vaccinated individuals, independent of gender, age, or BMI.

## Key findings

- The vaccine generated a mild but significant long-term memory against SARS-CoV-2.
- IFN-γ and granzyme B secretion increased after viral antigen exposure.
- Immune responses were consistent across different genders, ages, and BMIs.

## Abstract

Background: Vaccines are crucial for preventing infectious diseases, as both humoral and cellular immune responses play a vital role in combating viral infections. The cellular immune response is crucial against SARS-CoV-2, particularly with the emergence of new variants that evade antibody neutralization. This study focuses on the immune memory response in individuals who have been vaccinated with the Sinopharm BBIBP-CorV vaccine. Methods: A cross-sectional study evaluated lymphocyte subpopulations using flow cytometry in 52 vaccinated adults (30 females, 22 males) who had been exposed to SARS-CoV-2 or diagnosed with COVID-19. Conducted from February to June 2023 during the Omicron variant’s circulation, this study assessed antigens—CD154 in CD4+ T cells, CD107 and CD314 in CD8+ T cells, CD314 in NK cells, and CD86 in CD19 B cells—after stimulation with viral peptides and an inactivated virus. Granzyme B and IFN-γ were quantified using ELISA. Results: The memory response, regardless of gender, age, or Body Mass Index (BMI), was mild but significant upon exposure to a viral antigen or inactivated virus. An increase in the secretion of IFN-γ and granzyme B was also observed. Conclusions: It is suggested that the vaccine was able to generate a mild long-term memory against the SARS-CoV-2 virus in vaccinated adult individuals, independent of gender and BMI.

## Linked entities

- **Proteins:** CD40LG (CD40 ligand), KLRK1 (killer cell lectin like receptor K1), CD86 (CD86 molecule), CD19 (CD19 molecule), IFNG (interferon gamma)
- **Diseases:** SARS-CoV-2 (MONDO:0100096), COVID-19 (MONDO:0100096)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** KLRK1 (killer cell lectin like receptor K1) [NCBI Gene 22914] {aka CD314, D12S2489E, KLR, NKG2-D, NKG2D}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, GZMB (granzyme B) [NCBI Gene 3002] {aka C11, CCPI, CGL-1, CGL1, CSP-B, CSPB}, CD40LG (CD40 ligand) [NCBI Gene 959] {aka CD154, CD40L, HIGM1, IGM, IMD3, T-BAM}, CD19 (CD19 molecule) [NCBI Gene 930] {aka B4, CVID3}, CD86 (CD86 molecule) [NCBI Gene 942] {aka B7-2, B7.2, B70, BU63, CD28LG2, CD86 v6}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}
- **Diseases:** COVID-19 (MESH:D000086382), viral infections (MESH:D014777), infectious diseases (MESH:D003141)
- **Species:** Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049]

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12293013/full.md

---
Source: https://tomesphere.com/paper/PMC12293013